Követés
Mo Huang
Mo Huang
Associate Director, Biostatistics, Pfizer
E-mail megerősítve itt: pfizer.com - Kezdőlap
Cím
Hivatkozott rá
Hivatkozott rá
Év
SAVER: gene expression recovery for single-cell RNA sequencing
M Huang, J Wang, E Torre, H Dueck, S Shaffer, R Bonasio, JI Murray, ...
Nature Methods 15 (7), 539-542, 2018
7392018
Systematic analysis of splice-site-creating mutations in cancer
RG Jayasinghe, S Cao, Q Gao, MC Wendl, NS Vo, SM Reynolds, Y Zhao, ...
Cell reports 23 (1), 270-281. e3, 2018
2542018
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
JS Weber, MS Carlino, A Khattak, T Meniawy, G Ansstas, MH Taylor, ...
The Lancet 403 (10427), 632-644, 2024
2362024
Data Denoising with transfer learning in single-cell transcriptomics
J Wang, D Agarwal, M Huang, G Hu, Z Zhou, C Ye, NR Zhang
Nature Methods 16 (9), 875-878, 2019
1862019
Gene expression distribution deconvolution in single-cell RNA sequencing
J Wang, M Huang, E Torre, H Dueck, S Shaffer, J Murray, A Raj, M Li, ...
Proceedings of the National Academy of Sciences 115 (28), E6437-E6446, 2018
1332018
Design of an expression system to enhance MBP-mediated crystallization
T Jin, W Chuenchor, J Jiang, J Cheng, Y Li, K Fang, M Huang, P Smith, ...
Scientific reports 7, 40991, 2017
612017
MicrobiomeExplorer: an R package for the analysis and visualization of microbial communities
J Reeder, M Huang, JS Kaminker, JN Paulson
Bioinformatics 37 (9), 1317-1318, 2021
262021
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study
GP Gregory, S Kumar, D Wang, D Mahadevan, P Walker, ...
Blood advances 6 (4), 1232-1242, 2022
252022
The structure of the CARD8 caspase-recruitment domain suggests its association with the FIIND domain and procaspases through adjacent surfaces
T Jin, M Huang, P Smith, J Jiang, TS Xiao
Structural Biology and Crystallization Communications 69 (5), 482-487, 2013
192013
Dimension reduction and denoising of single-cell RNA sequencing data in the presence of observed confounding variables
M Huang, Z Zhang, NR Zhang
bioRxiv, 2020.08. 03.234765, 2020
142020
Structure of the caspase-recruitment domain from a zebrafish guanylate-binding protein
T Jin, M Huang, P Smith, J Jiang, TS Xiao
Structural Biology and Crystallization Communications 69 (8), 855-860, 2013
142013
Crystal structure of human NLRP12 PYD domain and implication in homotypic interaction
T Jin, M Huang, J Jiang, P Smith, TS Xiao
PloS one 13 (1), e0190547, 2018
112018
73P Association between homologous recombination repair mutations and response to pembrolizumab (pembro) plus olaparib (ola) in metastatic castration-resistant prostate cancer …
E Yu, JM Piulats, G Gravis, P Fong, T Todenhöfer, B Laguerre, J Arranz, ...
Annals of Oncology 32, S387, 2021
102021
BreakPoint Surveyor: a pipeline for structural variant visualization
MA Wyczalkowski, KM Wylie, S Cao, MD McLellan, J Flynn, M Huang, ...
Bioinformatics 33 (19), 3121-3122, 2017
52017
Phase 1b study of pan‐AKT inhibitor vevorisertib alone or with paclitaxel or fulvestrant in PIK3CA/AKT/PTEN‐mutated advanced solid tumors
S Pant, E Hamilton, SV Ulahannan, JF Strauss, FS Braiteh, M Huang, ...
Cancer 129 (12), 1919-1929, 2023
42023
Phase 1b Trial of Anti-Immunoglobulin-like Transcript 3 Monoclonal Antibody MK-0482 Monotherapy in Relapsed/Refractory Acute Myeloid Leukemia and Chronic Myelomonocytic Leukemia
GC Issa, D Lavie, A Przespolewski, SK George, M Huang, M Chen
Blood 140 (Supplement 1), 11759-11760, 2022
12022
Online Single-cell RNA-seq Data Denoising with Transfer Learning
B Kang, E Abeysinghe, D Agarwal, Q Wang, S Pamidighantam, M Huang, ...
Practice and Experience in Advanced Research Computing 2020: Catch the Wave …, 2020
12020
A Statistical Framework for Denoising Single-cell RNA Sequencing Data
M Huang
University of Pennsylvania, 2020
12020
Intratumoral or Subcutaneous MK-2118, a Non-Cyclic Dinucleotide STING Agonist, With or Without Pembrolizumab for Advanced or Metastatic Solid Tumors or Lymphomas
JJ Luke, RF Sweis, JR Hecht, R Schneider, MN Stein, T Golan, TA Yap, ...
Clinical Cancer Research, 2025
2025
A phase 1b study of the ERK inhibitor MK-8353 plus pembrolizumab in patients with advanced solid tumors
NJ Lakhani, H Burris III, WH Miller Jr, M Huang, LC Chen, LL Siu
Investigational New Drugs 42 (5), 581-589, 2024
2024
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20